Plasma-Focused Merger Sends Bio-Aesthetics Stock Up 125%

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.

You know how AI is shaking up everything from finance to film?

Well, it’s making serious moves in healthcare too—and this under-the-radar tech company might be onto something huge.

They’ve developed a tool called Vision AI that can detect eye diseases like diabetic retinopathy in seconds.

No bulky equipment. No long wait times. Just fast, web-based diagnostics that could help stop blindness before it starts.

With chronic diseases on the rise and aging populations straining healthcare systems, early detection like this isn’t just nice to have—it’s game-changing.

The company is heading into FDA trials, expanding into Latin America, and already looking at major licensing deals.

If you’ve been looking for the next big thing in healthtech—this might be it.

Get the full story and see why early eyes on this could lead to outsized gains.

U.S. stocks closed mixed today as gains in tech, led by Nvidia, were offset by weak bank earnings and signs that tariffs may be driving inflation higher, clouding the outlook for Fed rate cuts.

Blackstone (NYSE: BX) is committing $25 billion to develop data centers and natural gas power plants across Pennsylvania.

The firm plans to co-locate both infrastructure types, placing data centers directly alongside energy generation sites to reduce delays caused by grid congestion, permitting, and transmission bottlenecks.

The initiative includes partnerships with regional utilities to build natural gas power facilities specifically designed to supply high-demand computing operations.

Blackstone has already identified multiple sites and expects the project to support rapid deployment of AI workloads by securing power access at the source.

For investors, this capital allocation reflects a focused strategy built around asset control, predictable revenue, and long-term infrastructure utility.

Blackstone is positioning itself to benefit from rising demand for AI-related power while locking in exposure to tangible assets that can scale with enterprise growth.

Data centers paired with dedicated energy supply allow for stronger cost predictability, reduced downtime, and long-term service agreements with institutional clients.

This approach also gives Blackstone flexibility across multiple revenue streams, including wholesale power generation, private infrastructure leasing, and enterprise cloud partnerships.

It aligns the firm with both near-term AI momentum and longer-term energy resilience initiatives without relying on consumer applications or volatile software trends.

The Pennsylvania project is a direct response to one of the most immediate constraints facing AI expansion: power availability.

By solving for energy and computing together, Blackstone is building an asset base that supports the physical side of digital transformation, with clear monetization potential for years to come.

While headlines focus on the same overhyped AI names, a bigger opportunity is taking shape — and it’s flying under the radar.

A new report reveals 9 AI companies with real U.S. operations, accelerating revenue, and deep AI integration. These aren’t speculative plays — they’re positioned to benefit from a massive shift in how and where AI is being built.

This free guide includes:

…plus 6 more names with major upside potential.

The early window on these opportunities may be closing — now’s the time to see what’s coming next.

[Get your FREE copy now]

Coca-Cola (NYSE: KO) is reshaping its global footprint by doubling down on an asset-light bottling strategy that hands off production and distribution to local partners.

After years of refranchising, the company has now shifted the majority of its bottling operations to independent operators, freeing up capital and reducing supply chain risk.

The company’s model relies on tight integration with its partners while stepping back from ownership of bottling plants and logistics infrastructure.

That shift has enabled Coca-Cola to focus on brand building, product innovation, and global marketing, while allowing regional bottlers to handle the complexity of manufacturing and last-mile delivery.

For investors, this is more than an efficiency play.

The strategy is designed to expand margins, lower capital intensity, and protect Coca-Cola’s operating model from trade shocks, tariffs, and regional disruptions.

Local production also strengthens the brand’s image as a domestic player in key markets, supporting both consumer trust and government relations.

Those evaluating Coca-Cola’s long-term trajectory should see this strategy as a structural advantage.

With reduced exposure to asset-heavy bottling costs, the company can scale more quickly in emerging markets, maintain pricing flexibility, and preserve brand control without the drag of direct distribution overhead.

While competitors like PepsiCo and Keurig Dr Pepper still operate more integrated models, Coca-Cola’s approach favors margin growth over vertical control.

The result is a simplified, focused system that prioritizes profitability through local alignment and global brand strength.

As we dive into Q2 2025, the stock market is buzzing with opportunities, and I’ve got the insider scoop just for you.

I’ve handpicked the Top Seven Stocks for this quarter, offering you a clear roadmap for growth as the year progresses.

Here’s what makes this guide indispensable:

This isn’t merely a list; it’s your chance to seize the market’s hottest opportunities before they pass you by.

[Get Your Free Guide Now]

Retail stocks don’t always get much attention in the middle of a tech-led market rally. But seasonal catalysts matter.

And with U.S. households expected to spend over $1,200 per student on school supplies this year, the back-to-school season may quietly drive the next leg for two well-positioned names.

Walmart (NYSE: WMT) Still Sets the Standard

Walmart is rarely flashy, but it is almost always relevant. After a five-year return of more than 140 percent, WMT stock is sitting near its highs.

Investors may think most of the upside is priced in. However, the back-to-school cycle favors Walmart, particularly as middle-income families remain focused on value.

Unlike discretionary retailers that depend on promotional activity, Walmart’s core traffic benefits from essential spending.

School supplies, lunchbox staples, and budget clothing all drive foot traffic in August.

Analysts see 11 percent upside from current levels, and the company’s scale advantage means price competition plays directly into its strengths.

Walmart’s guidance for fiscal 2026 was conservative. But even a modest earnings beat could be enough to push shares through resistance.

While the valuation isn’t cheap, the market continues to reward consistency, and Walmart keeps delivering it.

DICK’S Sporting Goods (NYSE: DKS) Taps a Broader Playbook

DICK’S doesn’t just sell gym shorts. It’s becoming a full-spectrum back-to-school player as demand for athletic gear, cleats, sneakers, and team uniforms kicks up.

This year’s DICK’S Deal Days summer event captured early traffic, and the company’s omnichannel model is showing real traction.

DKS stock has already rebounded strongly from its 2024 lows, but it still remains well below its highs.

Analysts have raised price targets over the past two months, with Bank of America calling for $240 per share.

With the stock trading in the low 200s, there’s room for a push if sales hold up.

The pending acquisition of Foot Locker could become a strategic edge.

It won’t directly affect back-to-school earnings, but investors may start pricing in future cross-sell opportunities.

Together, DICK’S and Foot Locker will control an even larger share of student athletic spending.

Retail Timing Matters More Than It Seems

Walmart and DICK’S are capitalizing on a seasonal tailwind at a time when many consumer names are still adjusting to rate pressure and tariff uncertainty.

The difference is that school-year purchases are often non-negotiable. That means these two retailers can lean into a captive customer base while competitors fight for attention.

For investors looking beyond the usual AI and energy names, WMT and DKS offer something simple: clarity, strong demand, clear catalysts, and operating leverage when it counts.

Why These Stocks Could Stay Hot After Summer

The best retail trades aren’t always about holiday blowouts. They’re often about timing, supply chain strength, and a read on predictable demand.

As school spending increases, Walmart and DICK’S are doing more than just showing up.

They’re stepping in when parents open their wallets and shoppers make decisions fast. That’s the kind of advantage Wall Street eventually pays for.

👉 Click here to get our closing report to your cell for free!

Longevity Health Holdings Inc [XAGE] $5.96 (+125.33%)

Longevity Health Holdings shares jumped after announcing a merger with fast-growing plasma firm THPlasma, expected to drive future revenue and EBITDA growth.

USA Rare Earth Inc [USAR] $15.54 (+31.14%)

USA Rare Earth rallied in sympathy with MP Materials following its $500 million Apple deal, fueling investor hopes for similar rare-earth partnerships.

MP Materials Corp [MP] $58.25 (+20.05%)

MP Materials shares surged to a record high after the company announced a $500 million deal with Apple to supply recycled rare-earth magnets from its U.S. facilities.

Amaze Holdings Inc [AMZE] $6.94 (-39.16%)

Amaze Holdings shares fell as investors appeared skeptical about the company’s surprise crypto pivot, viewing it as a distracting shift from its core low-calorie wine business.

Presidio Property Trust Inc [SQFT] $9.07 (-33.31%)

Presidio Property Trust fell sharply after announcing a discounted direct stock offering and warrant repricing, which raised dilution concerns.  

MiNk Therapeutics Inc [INKT] $28.01 (-31.03%)

MiNK Therapeutics plunged after announcing a $50 million at-the-market equity offering, overshadowing recent scientific breakthroughs.

There’s a small AI company flying way under Wall Street’s radar—but that might not last much longer.

They’ve built Vision AI, a web-based platform that can detect diabetic retinopathy and other serious eye diseases in seconds.

It’s fast, scalable, and fits perfectly into the growing demand for early detection and preventative care.

The stock is still cheap—but the setup is intriguing:

✅ Potential FDA approval on deck
✅ Early traction in Latin America
✅ Global rollout and licensing opportunities on the horizon

As AI rewires entire industries, healthcare is next—and this stock could be an early mover in one of the most critical areas: disease detection.

Click to see why this quiet AI Healthtech play might not stay quiet for long.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.